Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study

The COVID-19 pandemic requires the development of effective methods for the treatment of severe cases. We aimed to describe clinical outcomes and changes in inflammatory markers in Polish patients treated with tocilizumab. The medical charts of SARS-CoV-2-positive patients treated in the Department...

Descripción completa

Detalles Bibliográficos
Autores principales: Olewicz-Gawlik, Anna, Ginter-Matuszewska, Barbara, Kamiński, Mikołaj, Adamek, Agnieszka, Bura, Maciej, Mozer-Lisewska, Iwona, Kowala-Piaskowska, Arleta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745724/
https://www.ncbi.nlm.nih.gov/pubmed/35011848
http://dx.doi.org/10.3390/jcm11010107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745724/
https://www.ncbi.nlm.nih.gov/pubmed/35011848
http://dx.doi.org/10.3390/jcm11010107

Ejemplares similares